VITAFOXOVitaFOXO
$0.014
$0.0001
(0.88%)
Vol778.56
Fundamentals
Mkt Cap
$0.00
24H Volume
$778.56
7D High
$0.0153
FDV
$139,538.00
Circ Supply
0.00
Total Supply
10M
Max Supply
10M
24H High
$0.0143
24H Low
$0.0139
<
...
1
>
Bullish/Bearish Forum Sentiment
Indicates whether most users posting on a crypto’s stream over the last 24 hours are bearish or bullish.
0
25
50
75
100
Extremely
Bearish
Neutral
Bullish
Extremely
Bearish
Bullish
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Message Board Activity
Measures the total amount of chatter on a stream over the last 24 hours.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
Discussion Diversity
Measures the number of unique accounts posting on a stream relative to the number of total messages on that stream.
0
25
50
75
100
Extremely
Low
Normal
High
Extremely
Low
High
N/A
Last score
N/A
1 day ago
Sign Up / Log In
1 week ago
Sign Up / Log In
1 month ago
Sign Up / Log In
3 months ago
Sign Up / Log In
6 months ago
Sign Up / Log In
1 year ago
Sign Up / Log In
AboutThis project will design a new RNA therapeutic that nudges the longevity-linked FOXO3 gene into its health-promoting form to halt the tissue breakdown behind degenerative disc disease—opening a precise, scalable route to drugs that extend healthspan. Dr. Lorna Harries’ lab has identified an innovative way to modulate FOXO3, a well known and yet undrugged longevity target, and propose leveraging it to address chronic lower back pain stemming from degenerative disc disease. They plan to make short, lab-made modified RNA molecules (antisense oligonucleotides) that selectively switch FOXO3’s “good” message on, first in human cells and mini-disc models. Success would yield 1) a lead drug candidate, 2) proof it can restore disc health, and 3) the data needed for patenting and further development. The same molecules could later be adapted to treat many other age-related conditions, helping people stay healthy for longer.
DetailsCategories
Base EcosystemDecentralized Science (DeSci)
Date
Market Cap
Volume
Close
June 09, 2026
$0.00
$778.56
---
June 09, 2026
$0.00
$1,739.43
---
June 08, 2026
$0.00
$710.41
$0.014
June 07, 2026
$0.00
$545.94
$0.0135
June 06, 2026
$0.00
$1,249.74
$0.0138
June 05, 2026
$0.00
$1,403.97
$0.0138
June 04, 2026
$0.00
$2,163.72
$0.0145
June 03, 2026
$0.00
$2,183.53
$0.0152
June 02, 2026
$0.00
$337.17
$0.015
June 01, 2026
$0.00
$505.17
$0.0147